The agreement provides a worldwide, nonexclusive license to make, use, import and sell MXene materials for specified applications.

The licensing arrangement is intended to complement Xenica's existing rights for military and defense-related applications.

Expanding Industrial Applications

MXenes are a family of two-dimensional materials first discovered at Drexel University in 2011.

The materials have attracted research interest because of their electrical conductivity, high surface area and other properties that could support functional materials development.

Under the new agreement, Xenica can pursue additional commercial applications, including industrial coatings and composites, subject to the license's exclusions and other applicable intellectual property rights.

ECT identified energy storage applications such as supercapacitors and fast-charging batteries as another potential market.

PFAS water filtration is also included among the specified applications.

The new rights do not cover all possible MXene applications. Nonmilitary electromagnetic interference shielding, antennas and infrared shielding are excluded, with military applications addressed through a separate sublicense.

The license is therefore broader than Xenica's previous defense-focused rights, although it does not provide unrestricted access to every MXene-related technology or market.

Building a Manufacturing Platform

The announcement follows a series of transactions intended to establish a commercial MXene manufacturing platform.

ECT previously announced an exclusive license from Rice University for a Flash Joule Heating process to produce MXenes and two-dimensional amorphous carbon.

The company also secured access to Metallium Ltd.'s commissioned Gator Point reactor in the United States under a research, development and engineering arrangement.

This provides access to existing manufacturing infrastructure without requiring the immediate construction of a new production plant.

Additional arrangements include precursor supply for manufacturing development and licensing rights for defense applications.

ECT announced its initial MXene production in October.

The company said the new Drexel agreement adds industrial market access to that developing platform.

However, completion of ECT's acquisition of Xenica remains a condition of its planned commercialization strategy.

Commercialization and Qualification Remain Ahead

ECT identified several steps that must occur before commercial sales can begin.

These include demonstrating repeatable production, improving yield and material consistency, independently validating material characteristics and qualifying products with prospective customers.

The company must also establish production economics and reach commercial agreements.

Defense remains ECT's first intended commercial market, although the company expects to pursue selected industrial applications in parallel.

ECT Executive Chairman Faldi Ismail said the expanded licensing rights allow the business to develop opportunities in energy storage, coatings and filtration while maintaining its defense-market priorities.

For the coatings industry, the agreement establishes a potential route to future MXene materials development, but ECT has not announced a commercial coatings-grade product or application-specific performance results.

No coatings customer qualification or commercial supply agreement was disclosed.

The licensing development comes as coatings researchers continue investigating nanomaterials for potential improvements in electrical conductivity, barrier performance and other functional properties.

PCI previously reported on graphene additive development for protective coatings, including projects evaluating nanomaterial performance in infrastructure applications.

The agreement could broaden future access to MXene materials for coatings formulators, although manufacturing and qualification remain major development steps. Explore PCI's coverage of nanotechnology in coatings.